Two reports, covering two different transcatheter pulmonary valves for separate yet related indications, reassure that an evolving field is headed in the right direction, with options expanding to a wider population of patients with congenital heart disease. Transcatheter pulmonary valves (TPVs) placed within an existing dysfunctional right ventricular outflow tract (RVOT) conduit or bioprosthetic pulmonary valve show good long-term results, according to 10-year follow-up from the Melody (Medtronic) investigational device exemption (IDE) trial.
|